PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
November 7, 2013 | ISSUE NUMBER 325 VOL 11

Special Feature
Pharm Exec's Orphan Drug Pipeline Picks
Orphan drugs, with an exception or two, weren't covered in PharmExec's forthcoming 2014 Pipeline Report. However, several noteworthy orphan-designated drug candidates – representing big sales potential for their parents – are headed toward regulatory approval ...Read more

Healthcare
The Vanishing Rx Patient Assistant Programs?
Patient Assistant Programs (PAPs) have morphed amazingly from very simple, 1990s “temporary public policy band aids” into massive, highly valued prescription drug information and service platforms. But will they still be with us in 20 years? ...Read more

Healthcare Reform
Feds Takes a Pass on Co-Pay Offsets under Obamacare
The implosion of the Affordable Care Act’s vaunted healthcare.gov benefit enrollment process has obscured a far more critical issue for Big Pharma: how much leeway do companies have in promoting durable brand affiliations among the potentially millions of new patients with subsidized access to new medicines? ...Read more

Scivigilance – Pharmacovigilance in a box
Technology and process enhancements play a crucial role in effective management of pharmacovigilance.  Technology fosters collaboration between disparate teams, enables seamless flow of data, intuitive collection, processing and analysis of data. Cumulatively, effective combination of domain expertise, agile process and robust technology has allowed us to consistently demonstrate time savings, high quality, cost reductions, increased efficiency and absolute compliance.
The whitepaper examines the use of scientific expertise, LEAN process and technology to deliver enhanced efficiency and compliance.

Marketing
Twitter IPO Looks a Safe Bet for Pharma Marketers
The imminent Twitter IPO looks likely to cement the social network’s future — good news for pharma marketers that increasingly see the network as an important place to engage HCPs and the public, writes Peter Houston
...Read more

Earn an Online Master’s Degree from the University of Florida!
Advance your education and career by earning a Master of Science in Pharmaceutical Outcomes and Policy. Learn the skills necessary to compete in this new marketplace.
Our flexible program allows you to choose courses, offered online, from various specialties. Earn your master’s degree in two years or choose a graduate certificate in one of our specialty tracks.Visit our website to apply

Global
Europe’s ‘Tsunami of Lobbying and Legislation’
April might be – as T S Eliot suggested – the cruelest month, but for pharma in Europe, October was certainly a contender to win an award as the busiest one. Reflector reports on “a packed month of health and pharmaceutical events contributing to the future shape of Europe’s medicines industry”
...Read more

New E-Book- Lifecycle Solutions: Positioning Pharmaceuticals For Commercial Success
Time is risk. If time to market is slowed then the cost for a company is lost revenues, profits, and ultimately lost opportunities for patients. The message is clear. To compete and win, companies must wrest more value from every stage of a new product’s tightly projected lifecycle.Download Now.

Global
Pharm Exec Global Digest — Real World Evidence Special
In this issue: learning to live and work with the Real World Evidence future — integrating RWE into your business strategy as painlessly as possible; Retrospective Studies — real world data, real world applications; Outcomes Data — getting ROI on your HEOR; and more!
...Read more

Pharmaceutical Executive editorial staff proudly introduces PharmExec TV, their latest high quality pertinent content in a brand new industry-breaking format.Tune In Now.

Video
GSK’s Big Hopes for Vaccine Development
Sophie Biernaux, VP & vaccine development leader, malaria and Joe Cohen, advisor malaria vaccine program, at GSK Vaccines at PhRMA’s Research and Hope Awards ceremony on their impact of their award-winning vaccine program.
...View here

Oncology Data Management Innovations
Live Webinar: Wednesday, November 20, 2013 at 1:00 pm EST
Register Free at www.pharmexec.com/datamgmt

//Antares Pharma (Ewing, NJ) appointed Dr Bruce Freundlich as Senior Vice President, Medical.//UK-based Biotec Services International expanded its US presence with the appointment of Doug Basinger as US Business Development Manager. Mr Basinger is tasked with growing the company’s client base along the West Coast.//Celerion (Lincoln, NE) appointed Clayton Dehn as Executive Director, Metabolic Diseases.//SAFE-BioPharma Association (Fort Lee, NJ) elected Dr Greg Koski to its Board of Directors.//

November 13–14: Sponsor/CRO and Business Process Integration
Raleigh, NC.


November 13–15: 2013 HBA Leadership Conference
Boston, MA.


December 6: New York Pharma Forum's 24th Annual General Assembly
New York, NY.


January 28–29, 2014: 11th Annual Pharmaceutical Compliance Congress
Washington, DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

 

Survey
Which area of pharma has the global recession impacted the most?

Click To Vote
 

Quick Links

UK: The PPRS is Dead, Long Live the PPRS!

Top-Tier Recruiting for China Amid the Corruption Fallout

Pharm Exec Industry Audit Slide Show